Basic parameters of thrombophilia in ocular Behçet disease with posterior segment involvement
Related Experiment Video
Updated: Jun 21, 2026

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
Published on: June 4, 2021
M Citirik1, I C Haznedaroglu, K Teberik
1SB Ankara Ulucanlar Eye Education and Research Hospital, Ankara, Turkey. mcitirik@hotmail.com
Insights
Thrombophilic factors like activated protein C resistance and antithrombin III are altered in ocular Behçet disease (BD) with posterior segment issues. These changes occur in both active and inactive disease states compared to healthy individuals.
Area of Science:
- Ophthalmology
- Hematology
- Immunology
Background:
- Ocular Behçet disease (BD) is a chronic inflammatory condition affecting the posterior segment of the eye.
- Thrombophilia, an increased tendency to form blood clots, may play a role in the pathogenesis of ocular BD.
- Understanding thrombophilic parameters can offer insights into disease mechanisms and potential therapeutic targets.
Purpose of the Study:
- To evaluate basic thrombophilic parameters in patients with ocular BD involving the posterior segment.
- To compare these parameters during active and inactive disease phases.
- To contrast thrombophilic profiles in ocular BD patients with those of healthy controls.
Main Methods:
- A cohort study involving 30 patients in the active phase of ocular BD, 30 in the inactive phase, and 30 healthy controls.
- Measurement of plasma protein C, free protein S, antithrombin III, and activated protein C resistance.
- Statistical comparison of thrombophilic parameters across the three groups.
Main Results:
- Significantly altered levels of activated protein C resistance and antithrombin III were observed in both active and inactive ocular BD patients compared to controls (p<0.05).
- No significant differences were found in protein C and free protein S levels between ocular BD patients and controls (p>0.05).
- No significant variations in any tested thrombophilic parameters were detected between the active and inactive ocular BD groups (p>0.05).
Conclusions:
- Elevated activated protein C resistance and increased antithrombin III plasma levels are associated with posterior segment involvement in ocular BD.
- These findings suggest a thrombophilic tendency in ocular BD, particularly concerning posterior segment inflammation.
- Basic thrombophilic tests can aid in understanding the pathophysiology of ocular BD.
Aim:
To assess basic thrombophilic parameters in both active and inactive periods of the ocular Behçet disease (BD) with posterior segment involvement in comparison with those in healthy adults as controls.
Method:
Thirty patients within the active period of the ocular BD with posterior segment involvement, 30 patients within the inactive period of the ocular BD with posterior segment involvement and 30 age-and sex-matched healthy controls were included in the study. Plasma protein C, free protein S, antithrombin III and activated protein C resistance were measured in the studied groups.
Results:
Activated protein C resistance and antithrombin III levels were significantly altered in both active and inactive ocular BD patients when compared with those in the controls (p<0.05), whereas protein C and free protein S levels were not significantly changed within both groups (p>0.05). There was no difference among the active and inactive groups of BD for all of the studied blood tests (p>0.05).
Conclusion:
Activated protein C resistance together with increased antithrombin III plasma levels are associated with the posterior segment involvement in ocular BD based on the assessment of basic thrombophilic tests.
More Related Videos
06:15Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
08:50Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Related Concept Videos
Venous Thrombosis I: Introduction
Glaucoma: Overview
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies